SCHEMBL4947004

SCHEMBL4947004

Cc1[c]c(-c2ccco2)co1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.39
ALDH1A1 P00352 9/20 0.39
HPGD P15428 5/20 0.39
HSD17B10 Q99714 4/20 0.39
POLB P06746 3/20 0.39
MAPT P10636 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
MEN1 O00255 3/20 0.39
BLM P54132 3/20 0.39
KMT2A Q03164 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
PKM P14618 2/20 0.39
ALOX15 P16050 2/20 0.39
CASP1 P29466 2/20 0.39
PTPN7 P35236 2/20 0.39
RECQL P46063 2/20 0.39
CASP7 P55210 2/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17968518 0.68 ALDH1A1 (0.33) ALDH1A1LMNA
SCHEMBL1799678 0.67 ALDH1A1 (0.63) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL15637254 0.65 HSD11B1 (0.39) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL13484019 0.64 PDE10A (0.49) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL29118007 0.64 ALDH1A1 (0.39) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL8183045 0.64 ALDH1A1 (0.43) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL297554 0.64 ALDH1A1 (0.43) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL22640 0.64 ALDH1A1 (0.43) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL25757 0.63
SCHEMBL15863797 0.62 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008089034-A2 CYTOKINE INHIBITORS KEMIA, INC. (US) 2008-07-24 WO disclosed
EP-1261611-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-12-04 EP disclosed
WO-2001064678-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-07 WO disclosed